NDRA Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	110 731
Vidutinė apimtis	186 909
Rinkos kapitalizacija	3.34M
EPS	$0 ( 2024-05-14 )
Kita pelno data	( $-0.270 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.330
ATR14	$0.00500 (1.65%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Basenese Lou	Buy	600	Stock Options
2024-01-02	Harsh Michael	Buy	600	Stock Options
2024-01-02	Digiandomenico Anthony	Buy	600	Stock Options
2024-01-02	Tokman Alexander Y	Buy	600	Stock Options
2023-05-18	Thornton Michael Milos	Buy	15 000	Common Stock

INSIDER POWER
100.00
Last 100 transactions
Buy: 3 706 167 \| Sell: 432 712

Tūris Koreliacija

Ilgas: -0.25 (neutral)

Trumpas: 0.52 (weak)

Signal:(51.237) Neutral

ENDRA Life Sciences Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
JWEL	0.943
LULU	0.93
SHC	0.923
EZGO	0.921
GOCO	0.916
IMRX	0.916
DCFC	0.915
AZ	0.915
DXLG	0.915
ASPS	0.913

10 Labiausiai neigiamai susiję koreliacijos
KEQU	-0.944
EML	-0.93
IVCB	-0.929
SWAV	-0.929
FUSN	-0.927
CDXC	-0.907
LABP	-0.907
PESI	-0.905
BCSA	-0.904
IMPPP	-0.904

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

ENDRA Life Sciences Inc Koreliacija - Valiuta/Žaliavos

0.14
( neutral )

0.10
( neutral )

0.00
( neutral )

0.15
( neutral )

ENDRA Life Sciences Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2023
Pajamos:	$0
Bruto pelnas:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2022
Pajamos:	$0
Bruto pelnas:	$-234 258 (0.00 %)
EPS:	$-4.57

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-11.83

Financial Reports:

No articles found.

ENDRA Life Sciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.